Louise Emmett

Prof. Emmett is the Director of Theranostics and Nuclear Medicine at St Vincent’s Hospital Sydney, a conjoint professor of medicine at the University of New South Wales and clinical research leader at the Garvan Institute of Medical Research. Since joining the Nuclear Medicine and Positron Emission Tomography (PET) department at St. Vincent’s Hospital in 2012, Prof Emmett has been instrumental in developing the theranostics initiative at the St Vincent’s Campus, introducing new radiopharmaceuticals for clinical and research evaluation of cancer as well as setting up radiopharmacy production of a number of imaging and therapy tracers.

Prof. Emmett is heavily involved in multidisciplinary clinical development and cancer research, including both imaging and therapy. She is the principal investigator of a number of prospective randomised national trials in Australia, being a big believer in the power of clinical research to optimise treatments and improve patients’ lives. She is passionate about translational science, collaborating with biotechnology companies to bring promising theranostic agents into the clinic.

Prof.Emmett completed medical school at Auckland University (1992), New Zealand prior to completing her specialty training in Nuclear Medicine in Sydney and receiving her Fellow of the Royal Australasian College of Physicians (FRACP) qualification in 1999. She undertook a specialty fellowship in Nuclear Cardiology at the University Health Network in Toronto, Canada in 2001, and completed a Doctorate of Medicine in Nuclear Cardiology through Auckland University in 2014. Prof Emmett is a clinical professor with the University of New South Wales with a strong interest in research. She has published over 100 original papers in peer-reviewed journals in the last 10 years, has received a number of grants for clinical research and has presented at numerous national and international meetings.